January 2025 in “Clinical Cosmetic and Investigational Dermatology” This case series involving 10 patients treated with clascoterone cream 1% for acne vulgaris found it effective and well-tolerated, regardless of severity, age, gender, or ethnicity, and noted additional benefits for related skin conditions.
In this study, a machine-learning model was evaluated for its ability to categorize various hair conditions, achieving high accuracy and balance between precision and recall, with an overall accuracy of 97% in detecting hair problems.
October 2023 in “Journal of the American Academy of Dermatology” This source reports that clascoterone cream has been approved in the U.S. for treating acne vulgaris in patients aged 12 and older, suggesting it works by competing with dihydrotestosterone at androgen receptors to mitigate acne's effects.
September 2023 in “Pakistan Journal of Medical & Health Sciences” This study found that among male hair transplant patients, most had a single crown hair whorl pattern, which was more often located centrally on the scalp compared to dual or undetectable patterns.
This study concluded that removing alopecia and mucous membrane components from the CLASI-A score limits the ability to capture crucial clinical information about cutaneous lupus erythematosus activity, recommending their retention.
June 2023 in “Aesthetic Plastic Surgery” This study introduces the PRECISE scale, a quantitative tool to classify androgenetic alopecia, aiming to improve planning and outcomes for hair transplantation surgeries by evaluating the whole hairless and thinning areas.
January 2022 in “Journal of Pharmaceutical Negative Results” This study found that a VGG-SVM model using machine learning techniques achieved 98.31% accuracy in distinguishing alopecia areata from healthy hair based on image datasets.
December 2021 in “Benha Journal of Applied Sciences” This study found that plasma Claudin 3 levels were linked to alopecia areata severity among patients compared to healthy controls.
August 2018 in “Journal of The American Academy of Dermatology” A 54-year-old man with painful skin blisters and fever was diagnosed with Sweet syndrome and successfully treated with corticosteroids.
July 2018 in “IP Indian Journal of Clinical and Experimental Dermatology” This case report describes a 52-year-old male with folliculitis decalvans, initially resembling lupus vulgaris, who was successfully treated with minocycline and clarithromycin.
May 2018 in “International Society of Hair Restoration Surgery” This announcement describes job openings at a boutique hair restoration center in Atlanta and reports no clinical results; it emphasizes quality over quantity in their procedures.
April 2018 in “Journal of Investigative Dermatology” This study found that claudins CLDN1 and CLDN3 are crucial for maintaining proper hair follicle structure in mice, and their dysregulation may lead to telogen hair loss.
March 2018 in “International Society of Hair Restoration Surgery” This announcement outlines job opportunities at the Anderson Center for Hair and provides no clinical research findings.
January 2018 in “International Society of Hair Restoration Surgery” This announcement details employment opportunities at the Anderson Center for Hair and includes no clinical research findings.
September 2017 in “International Society of Hair Restoration Surgery” This listing describes job openings at a hair restoration clinic that emphasizes quality, ethics, and natural results; no research findings are reported.
July 2017 in “International Society of Hair Restoration Surgery” This abstract describes job opportunities at Anderson Center for Hair in Atlanta, Georgia, and reports no research findings.
May 2017 in “International Society of Hair Restoration Surgery” This listing describes job openings for a hair restoration physician and technicians at a new boutique center in Atlanta; no research findings are reported.
April 2012 in “Informa Healthcare eBooks” Classifying hair diseases, like alopecia, is difficult and needs more research to understand their causes.
December 2007 in “Röntgenpraxis” This review discusses various treatments for androgenic alopecia, highlighting FDA-approved options and other commonly used therapies, but reports no new clinical results.
July 2007 in “Clinical Risk” The claimant sued for negligence after a hair treatment caused harm and distress, and the defendant responded after legal action started.
January 2004 in “uO Research (University of Ottawa)” This study found that overexpression of Claudin 6 in mice led to incomplete epidermal formation and hair abnormalities, suggesting its crucial role in skin differentiation and hair follicle development.
July 2000 in “Dermatologic Surgery” Dr. Yarborough denied endorsing Derma Genesis and was mistakenly represented due to his office manager's error; also, over 30% of tested skin products were contaminated with bacteria.
March 1991 in “Archives of Dermatology” This text is a website user interface and does not include an abstract summary or research findings.
February 1991 in “Archives of Dermatology” The document lists dermatology job ads across the U.S. with good pay and benefits.
The document listed various medical job opportunities with competitive benefits and living conditions.
This abstract contains no research findings; it outlines website features and access options for the JAMA network's publications.
July 2022 in “Journal of Investigative Dermatology” This study suggests that using a non-medicated, hypo-allergenic scalp clarifying shampoo may improve hair volume and reduce shedding in women with lichen planopilaris and female pattern hair loss.
March 2018 in “John Wiley & Sons, Ltd eBooks” This chapter reviews classification and techniques of surgical therapies for treating stable, recalcitrant vitiligo, highlighting their role alongside non-surgical methods for small, specific cases.
January 2016 in “Springer eBooks” This article reviews the classification systems for androgenetic alopecia and reports no new research findings.
This article reviews classification systems for androgenetic alopecia in men and women and reports no new research findings.